HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

AMWL

American Well Corporation (NYSE)

Healthcare — Health Information Services

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

None 5 analysts
$9.12
$0.25 (-1.94%)
Target: $7.50 (-17.8%)
Sign in to add AMWL to a watchlist or set price alerts.

Price History

Fundamentals

Market Cap$157.56M
P/E Ratio (TTM)-
Forward P/E-5.61
EPS (TTM)$-5.43
Dividend Yield-
Profit Margin-37.02%
Revenue Growth-
ROE-
Debt/Equity-
Recommendation None
Analyst Target$7.50
Analysts5
Indexes NYSE

Technical Indicators

RSI (14)59.7
Beta1.70
SMA 20-
SMA 40-
52-Week High-
52-Week Low-
50-Day Avg-
200-Day Avg-
Avg Volume-
Volume-

Performance Analysis

NEUTRAL

AMWL presents a mixed picture with both positive and negative indicators.

+ RSI at 59.7 shows positive momentum.
- Operating at a loss with -37.0% margin.
~ Wall Street consensus is "none" from 5 analysts.
- Average analyst target of $7.50 implies 17.8% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 01, 2026 11:46 UTC

Back to Screener Export Report